Apoorva Mandavilla wrote about new Alzheimer’s drugs which show promise. Alzheimer’s disease is characterized by loss of cognitive function and results in mental decline. Most Alzheimer’s treatments target a protein called amyloid which is the main protein component of the plaque that forms in the brain. A new drug, Rember, is the first to target tangled, abnormal fibers of a protein called tau...